Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK5 inhibitors(Cyclin-dependent kinase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19N3O |
InChIKeyAGVIDDQHAQSPIZ-UHFFFAOYSA-N |
CAS Registry865317-30-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | 28 Dec 2017 |